Meet the Scientist - November 2013

Printer-friendly versionPrinter-friendly version

Meet the Scientist Webinar SeriesPlease join us by phone or on the web for our Meet the Scientist Webinar Series! Hear leading mental health researchers present the latest in new technologies, diagnostic tools, early intervention strategies and next-generation therapies for mental illness.


 

Webinar Details:

Topic: "Pharmacotherapy of PTSD"
When: Tuesday, November 12, 2:00 p.m.–3:00 p.m. EST

View Recordings


download slideshow presentation
download slideshow presentation

Speaker:

John H. Krystal, M.D. of the American College of NeuropsychopharmacologyJohn H. Krystal, M.D.
Foundation Scientific Council Member
NARSAD Grantee, 1997, 2000, 2006
Robert L. McNeil Jr. Professor of Translational Research
Chair, Department of Psychiatry
Chief of Psychiatry, Yale-New Haven Hospital
Director, National Institute on Alcohol Abuse and Alcoholism Center for the Translational Neuroscience of Alcoholism
Director, Clinical Neuroscience Division, VA National Center for PTSD
Director, VA Alcohol Research Center
Medical Director, Schizophrenia Biological Research Center, DVA

Dr. Krystal is an expert on the neurobiology and treatment of schizophrenia, post-traumatic stress disorder and alcoholism. In these areas, he has linked experimental psychopharmacology, neuroimaging, and genetics to identify disturbances in the function of brain circuits, particularly those involving glutamate and GABA that might be targeted in the development of new treatments. He developed the use of ketamine as a probe of glutamate receptor function in brain and behavior disorders. This work contributed to the development of mGluR2/3 agonist treatments for schizophrenia and riluzole and NMDA receptor antagonist treatments for depression and alcoholism.

President of the American College of Neuropsychopharmacology, Dr. Krystal has completed residency at Yale.

 

Moderator:

Jeffrey Borenstein, M.D.
President & CEO, Brain & Behavior Research Foundation

Jeffrey Borenstein, M.D., Acting President and CEO of the Brain & Behavior Research FoundationJeffrey Borenstein, M.D., joined the Brain & Behavior Research Foundation in 2012 as Chief Medical Officer and was appointed as President & Chief Executive Officer at the start of 2013. Dr. Borenstein has more than two decades of experience in health and non-profit leadership. He is former CEO/Medical Director of Holliswood Hospital, where he served from 1996 to 2012. He is a board-certified psychiatrist and the Host of the award-winning series, “Healthy Minds,” which is broadcast on public television stations across the United States. He is Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association.

An active contributor to the psychiatric field  for more than three decades, Dr. Borenstein currently chairs the Council on Communications of the American Psychiatric Association, the Mental Health Services Council of NY State, and the Section on Psychiatry, NY Academy of Medicine, where he is a Fellow. Among the many honors to his credit are the National Alliance on Mental Illness of NY State Connie Lieber Award, the American Psychiatric Association Special Presidential Commendation and the Federation of Organizations Community Mental Health Man of the Year Award. 

Dr. Borenstein is Associate Clinical Professor of Psychiatry, Columbia University College of Physicians & Surgeons. He is a graduate of Harvard College and New York University School of Medicine.

View schedule of other upcoming webinars at: bbrfoundation.org/webinar

For other upcoming events, visit: bbrfoundation.org/events